Tag: SPCL

Blue Horseshoe Stocks: SBFM Update, Options Idea & More

Sunshine Biopharma, Inc. SBFM

We initially tagged SBFM for observation four sessions back (exactly one week ago) after noticing abnormal activity the day prior, and were immediately met with a big run from .008-.0183 (129%) that first day. In each of the sessions since the stock has recorded higher lows and to open up 2016 trading yesterday the stock jumped to impressive new highs.

From a daily low of .013 SBFM made a nice intraday move totaling 65% as pushed its upper limits to a .0214 on heavy volume.  That represented an overall swing in the three sessions since we’ve  been tracking it to a highly respectable 168%

The overall uptrend kicked off with the revelation that the company had acquired all of the worldwide patents for its “anticancer compound”, Adva-27a >>>VIEW PR

Breathe eCig Corp. BVAP

BVAP was an item of interest in our report from last Wednesday, and it took only three sessions to realize the big move we suspected might be in store. The company has been consistently retiring its convertible debt in tranches over the past several months, and a deal that will allow for full repayment was the subject of an announcement that hit wires yesterday. (VIEW PR)

That news helped to push the stock to a new high of .0039, which from our observed low of .0015 on the day of our initial alert, goes down in the books as a three-day swing of 160%

Smith & Wesson Holding Corp. SWHC – Options Idea

SWHC caught our eye in the premarket this morning and struck us as a possible opportunity to see some big intraweek swings in some options calls. As the Obama administration presses for heightened restrictions on firearms, gun manufacturers are reporting exceptionally increased demand.

Add in yesterday’s post-market earnings which reflected bolstered sales and 2016 guidance, and we have a potential recipe for continued bullishness.

As a result, we want to put a range of options on our radars; specifically the SWHC Weekly $24-26 Calls. We’ll be in the lookout for a possible dip-and-rip scenario to kick things off, and will remain interested as long as the dip carries the stock no lower than $24.

Extended Watchlist:
AHIX, TALK, SPCL, HCTI

Blue Horseshoe Stocks: Potential Bottom-Plays & More

Solaris Power Cells, Inc. SPCL

We’ve got a news play hitting our scanner this morning in SPCL, and as it turns out, the chart is looking ripe for a nice move. As we’ve pointed out on the following snapshot, the stock is trading near a relative bottom, having just registered a new 52-week low just two weeks ago.

Our regular readers are well acquainted with our history of banking excellent gains off a good rebound play. SPCL could be next in line on that front, so we’ll keep a sharp eye on it to start the week.

In addition to trading near a bottom, we’re seeing signs of a very oversold stock with a lot of room to the upside:

PALM SPRINGS, Calif., July 13, 2015 (GLOBE NEWSWIRE) — Solaris Power Cells, Inc. the creators of the Solaris PESATM “Passive Electron Storage Array”™, (the “Company”) (OTCQB:SPCL)  the Board of Directors of Solaris Power Cells today announced the appointment of long-time energy policy leader Robert Foster to lead Solaris Energy Storage Advisory Board, effective July 10th 2015. >> FULL PR

OncoGenex Pharmaceuticals, Inc OGXI

OGXI announced this morning that one of its cancer treatments, currently in Phase III trials has passed rigorous criteria and
that trials for patients with non-small cell lung cancer will proceed as planned. The stock is gapping up in premarket trading, and we’re going to monitor its activity as the session commences.

BOTHELL, Wash. and VANCOUVER, British Columbia, July 13, 2015 /PRNewswire/ — OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) announced today that its Phase 3 ENSPIRIT trial evaluating custirsen in the treatment of advanced or metastatic non-small cell lung cancer (NSCLC) is continuing as planned per the recommendation of an Independent Data Monitoring Committee>> FULL PR


Frontline, Ltd. FRO

We’ve got a long history with FRO that stretches all the way back to 2012. We tagged FRO in Thursday’s premarket report, after it hit a relative bottom of 2.21 on Wednesday. Our observed low following Thursday’s alert was 2.32, and on Friday we saw as the stock inched up to a high of 2.43. We’re going to be on the lookout for further gains; the stock is gapping up slightly in early trading this morning.

An added element to the story is an opinion article that came across the wires last week pertaining to the perceived undervaluation of FRO. It points to a potential longer-term uptrend in the cards, stating that while this year’s earnings growth is expected to top last year’s by more than 200%, that hasn’t really been reflected in the share price. We suggest our subscribers click the following link and give it a read >> VIEW ARTICLE

Extended Watchlist:
PSDV, GILT, FREE, GRPN, DANG, CLTX, DRYS